The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kutsakina D.A.

Sechenov First Moscow State Medical University

Kraus D.V.

Sechenov First Moscow State Medical University

Privalova E.V.

Sechenov First Moscow State Medical University

Ilgisonis I.S.

Sechenov First Moscow State Medical University

Modern diagnostic methods for early detection of vascular toxicity associated with antitumor therapy

Authors:

Kutsakina D.A., Kraus D.V., Privalova E.V., Ilgisonis I.S.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2026;19(1): 91‑97

DOI: 10.17116/kardio20261901191

Read: 310 times

Buy for 300₽
Contact the author
Table of contents

MODERN DIAGNOSTIC METHODS FOR EARLY DETECTION OF VASCULAR TOXICITY ASSOCIATED WITH ANTITUMOR THERAPY
MODERN DIAGNOSTIC METHODS FOR EARLY DETECTION OF VASCULAR TOXICITY ASSOCIATED WITH ANTITUMOR THERAPY

To cite this article:

Kutsakina DA, Kraus DV, Privalova EV, Ilgisonis IS. Modern diagnostic methods for early detection of vascular toxicity associated with antitumor therapy. Russian Journal of Cardiology and Cardiovascular Surgery. 2026;19(1):91‑97. (In Russ.)
https://doi.org/10.17116/kardio20261901191

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Correlation between endo­thelial dysfunction and sensorineural hearing loss. Russian Bulletin of Otorhinolaryngology. 2025;(3):13-18
Biomarkers of endo­thelial dysfunction in asse­ssing degrees of the of coro­nary artery disease seve­rity and features of the ischemic heart disease clinical course in middle-aged men. Russian Journal of Preventive Medi­cine. 2025;(6):41-47
Hype­rtensive diso­rders of pregnancy as a risk factor for chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(6):114-119
Diagnostic stra­tegies for post-COVID syndrome. Russian Journal of Preventive Medi­cine. 2025;(6):126-130
Cesa­rean section in modern obstetrics: problems and ways to overcome them. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):5-18
Evaluation of the skeletal muscle index in predicting toxic complications of anti­tumor drug therapy in patients with gastric cancer. P.A. Herzen Journal of Onco­logy. 2025;(4):29-36
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
«Metabolic health» and endo­thelial function in women with poly­cystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):27-34
Resu­lts of a multicenter inte­rnational study on the effi­cacy and safety of Rema­xol in patients with drug-induced liver injury during anti­tumor therapy. P.A. Herzen Journal of Onco­logy. 2025;(5):26-33
Gene­tic predictors of the formation of placental insu­fficiency in patients with gestational diabetes mellitus without insu­lin requirement. Russian Journal of Human Reproduction. 2025;(5):103-110
Abstract:

Timely diagnosis of cancer treatment related cardiovascular toxicity significantly influences prognosis of cancer patients. Since endothelial dysfunction is the leading mechanism of cardiovascular diseases, assessment of structural and functional state of vascular system seems promising for early diagnosis of vascular toxicity. The article analyzes experience of non-invasive instrumental methods to detect vascular damage caused by antitumor therapy.

Keywords:

cardiooncology
antitumor therapy
vascular toxicity
endothelial dysfunction
instrumental diagnosis

Authors:

Kutsakina D.A.

Sechenov First Moscow State Medical University

Kraus D.V.

Sechenov First Moscow State Medical University

Privalova E.V.

Sechenov First Moscow State Medical University

Ilgisonis I.S.

Sechenov First Moscow State Medical University

Received:

28.01.2025

Accepted:

30.03.2025

Close metadata

References:

  1. Lyon AR, Lopez-Fernandez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).European Heart Journal. 2022;43(41):4229-4361. https://doi.org/10.1093/eurheartj/ehac244
  2. Chazova IE, Ageev FT, Aksenova AV, Vicenya MV, Gilyarov MYu, Martynyuk TV, Panchenko EP, Poltavskaya MG, Potievskaya VI, Trofimova OP, Fedotkina YuA. Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022). Eurasian Heart Journal. 2022;(1):6-79. (In Russ.). https://doi.org/10.38109/2225-1685-2022-1-6-79
  3. Gao F, Xu T, Zang F, Luo Y, Pan D. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment. Drug Design, Development and Therapy. 2024; 12(18):4089-4116. https://doi.org/10.2147/DDDT.S469331
  4. Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology.2012;52(6);1213-1225. https://doi.org/10.1016/j.yjmcc.2012.03.006
  5. Carrizzo A, Forte M, Lembo M, Formisano L, Puca AA, Vecchione C. Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases. Current Cancer Drug Targets. 2014;15(13):1231-1246. https://doi.org/10.2174/1389450115666141027110156
  6. Tacar O, Dass CR. Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes? Journal of Pharmacy and Pharmacology. 2013; 65(11):1577-89.  https://doi.org/10.1111/jphp.12144
  7. Terwoord JD, Beyer AM, Gutterman DD. Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacology & Therapeutics. 2022;237:108116. https://doi.org/10.1016/j.pharmthera.2022.108116
  8. Roos WP, Thomas AD, Kaina B. DNA damage and the balance between survival and death in cancer biology. Nature Reviews Cancer. 2016;16:20-33.  https://doi.org/10.1038/nrc.2015.2
  9. Wang L, Chen Q, Qi H, Wang C, Wang C, Zhang J, Dong L. Doxorubicin-induced systemic inflammation is driven by upregulation of Toll-like receptor TLR4 and endotoxin leakage. Cancer Research Journal. 2016;76(22):6631-6642. https://doi.org/10.1158/0008-5472.CAN-15-3034
  10. Elena LL, Mzhelskaya MM, Koldysheva EV, Klinnikova MG. Immunohistochemical evaluation of vasoendothelial growth factor receptor-2 (vegfr2) expression in rat cardiomyocytes under doxorubicin and betulonic acid amide administration. Siberian Scientific Medical Journal. 2018;38(6):5-12. (In Russ.). https://doi.org/10.15372/SSMJ20180601
  11. Hsu P-Y, Mammadova A, Benkirane-Jessel N, Désaubry L, Nebigil CG. Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies. Frontiers in Cardiovascular Medicine. 2021;27;8:694711. https://doi.org/10.3389/fcvm.2021.694711
  12. Polegato BF, Minicucci MF, Azevedo PS, Carvalho RF, Chiuso-Minicucci F, Pereira EJ, Paiva SA.R, Zornoff LA.M, Okoshi MP, Matsubara BB, Matsubara LS. Acute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in rats. Cellular Physiology and Biochemistry. 2015;35:1924-1933. https://doi.org/10.1159/000374001
  13. Grego-Bessa J, Gómez-Apiñaniz P, Prados B, Gómez MJ, MacGrogan D, de la Pompa JL. Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development. Circulation Research. 2023;133(11):927-943.  https://doi.org/10.1161/CIRCRESAHA.123.323321
  14. Versmissen J, Mirabito Colafella KM, Koolen SL.W, Danser AHJ. Vascular Cardio-Oncology: vascular Endothelial Growth Factor inhibitors and hypertension. Cardiovascular Research. 2019; 115(5):904-914.  https://doi.org/10.1093/cvr/cvz022
  15. Deac AL, Burz CC, Bocsan IC, Buzoianu AD. Fluoropyrimidine-induced cardiotoxicity. World Journal of Clinical Oncology. 2020;11(12):1008-1017. https://doi.org/10.5306/wjco.v11.i12.1008
  16. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation.2002;106(6):653-658.  https://doi.org/10.1161/01.cir.0000025404.78001.d8
  17. Shabrov AV, Galenko AS, Uspensky YuP, Loseva KA. Methods for diagnosing endothelial dysfunction. Bulletin of Siberian Medicine. 2021;20(2):202-209. (In Russ.). https://doi.org/10.20538/1682-0363-2021-2-202-209
  18. Naumova KV, Davydkin IL, Lomaia EG, Stepanova TYu, Kuzmina TP, Zammoyeva DB. Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications. Russian Journal of Cardiology. 2020;25(4S):4219. (In Russ.). https://doi.org/10.15829/1560-4071-2020-4219
  19. Kirichenko YuYu, Ilgisonis IS, Belenkov YuN, Privalova EV, Naymann YuI, Lyamin AM, Kozhevnikova MV, Korobkova EO, Khabarova NV, Ogorodnikov NV. The effect of chemotherapy on endothelial function and microcirculation in patients with gastric cancer. Kardiologiia. 2020;60(2):89-95. (In Russ.). https://doi.org/10.18087/cardio.2020.2.n908
  20. Budanova DA, Antyufeeva ON, Ilgisonis IS, Sokolova IYa, Belenkov YuN, Ershov VI, Bochkarnikova OV, Gadaev IYu. Assessment of the Dynamics of Markers for Direct Damage and Myocardial Dysfunction, Indicators of Endothelial Dysfunction in Patients With Indolent Lymphomas Before and After Anticancer Therapy. Kardiologiia. 2020;60(11):49-56. (In Russ.). https://doi.org/10.18087/cardio.2020.11.n1390
  21. Cardone M, Caro G, Amorosi B, Cristaudo A, Morrone A, Calvieri S, et al. Capillaroscopy: a new application for the evaluation of vascular side-effects induced by chemotherapy. Italian Journal of Dermatology and Venereology. 2021;156:84-88.  https://doi.org/10.23736/S2784-8671.20.06401-9
  22. Dalbeni A, Ciccarese C, Bevilacqua M, Benati M, Caimmi C, Cerrito L, Famà F, Iacovelli R, Mantovani A, Meneguzzi FMA, Minuz P, Montagnana M, Orsolini G, Rossini M, Tortora G, Viapiana O, Fava C. Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer. Cancers (Basel). 2018;28;11(1):30.  https://doi.org/10.3390/cancers11010030
  23. Masopustová A, Jehlička P, Huml M, Votava T, Trefil L, Kreslová M, Sýkora J. Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors — new applications. Physiological Research. 2018;67(6):903-909.  https://doi.org/10.33549/physiolres.933754
  24. Abuldinova OA, Prikhodko OB, Voytsekhovskiy VV, Goborov ND. Assessment of the contour analysis of the photoplethysmogram in healthy individuals of young age. Bulletin Physiology and Pathology of Respiration. 2020;(76):41-45. (In Russ.). https://doi.org/10.36604/1998-5029-2020-76-41-45
  25. Meacham LR, Chow EJ, Ness KK, Kamdar KY, Chen Y, Yasui Y, Oeffinger KC, Sklar CA, Robison LL, Mertens AC. Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. Cancer Epidemiology, Biomarkers & Prevention. 2010;19(1):170-81.  https://doi.org/10.1158/1055-9965.EPI-09-0555
  26. Parr SK, Liang J, Schadler KL, Gilchrist SC, Steele CC, Ade CJ. Anticancer Therapy-Related Increases in Arterial Stiffness: A Systematic Review and Meta-Analysis. Journal of the American Heart Association. 2020;9(14):e015598. https://doi.org/10.1161/JAHA.119.015598
  27. Filatova AYu, Vitsenya MV, Potekhina AV, Gavryushina SV, Pylaeva EA, Pestova AB, Stenina MB, Frolova MA, Shchinova AM, Klesareva EA, Afanasieva OI, Arefeva TI, Ageev FT. Atherosclerosis of brachiocephalic arteries and arterial stiffness in patients with breast cancer. Kardiologiia. 2019;59(1S):43-52. (In Russ.). https://doi.org/10.18087/cardio.2585
  28. Shabrov AV, Apresyan AG, Dobkes AL, Ermolov SU, Ermolova TV, Manasyan SG, Serdyukov SV. Current methods of endothelial dysfunction assessment and their possible use in the practical medicine. Rational Pharmacotherapy in Cardiology. 2016;12(6):733-742. (In Russ.). https://doi.org/10.20996/1819-6446-2016-12-6-733-742
  29. Anastasiou M, Oikonomou E, Theofilis P, Papamikroulis GA, Gazouli M, Kalogeras K, Lygkoni S, Pesiridis T, Goliopoulou A, Papatheodoridi A, Psyrri A, Zagouri F, Siasos G, Tousoulis D. Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients. Vascular Pharmacology. 2023;152:107195. https://doi.org/10.1016/j.vph.2023.107195
  30. Belenkov YuN, Ilgisonis IS, Khabarova NV, Kirichenko Yu.Yu. Modern Instrumental Methods of Diagnostics and Risk Assessment of Developing Antitumor Therapy Cardiovasculotoxicity. Kardiologiia. 2024;64(8):3-12. (In Russ.). https://doi.org/10.18087/cardio.2024.8.n2753
  31. Patel S, Franco FX, McDonald M, Rivera C, Perez-Villa B, Collier P, Moudgil R, Gupta N, Sadler DB. Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: a retrospective cohort analysis. Cardiooncology. 2024;10(1):1.  https://doi.org/10.1186/s40959-023-00196-9
  32. Lui M, Kim N, Zaghlol R, Joolharzadeh P, Deych E, Robinson C, Badiyan S, Woodard PK, Mitchell JD. Coronary artery calcium on lung cancer radiation planning CT aids cardiovascular risk assessment. Cardiooncology. 2024;10(1):80.  https://doi.org/10.1186/s40959-024-00283-5
  33. El-Sabbagh A, Osman MM, Fesler M, Helmy T, Parker N, Muzaffar R. Chemotherapy-induced coronary arteries calcium score deterioration as detected with unenhanced CT portion of FDG PET/CT. American journal of nuclear medicine and molecular imaging. 2018;8(5):303-310. 
  34. Deep K, Hardisky D, Tram NK, Chou T-H, Ettefagh L, Bobbey AJ, Audino AN, and Stacy MR. Monitoring of chemotherapy-induced vascular toxicity in pediatric, adolescent, and young adult lymphomas using PET/CT imaging. Circulation. 2021;144(1). https://doi.org/10.1161/circ.144.suppl_1.12510
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.